Insider · CIK 0001197014

ALAM JOHN J

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001197014

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+8,150 sh	—	—	8,150
2026-02-11	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+75K sh	—	—	75,000
2025-11-17	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+10.8K sh	$8.46	+$91.4K	1,484,078
2025-11-17	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+10.8K sh	$8.46	+$91.3K	12,500
2025-11-14	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+1,693 sh	$7.55	+$12.8K	1,473,271
2025-11-14	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+1,707 sh	$7.57	+$12.9K	1,707
2025-11-13	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+4,447 sh	$7.51	+$33.4K	1,471,578
2025-11-12	CRVOCervoMed Inc.P Purchase	Director, CEO & President, 10% Owner	PPurchase	+5,553 sh	$7.35	+$40.8K	1,467,131
2025-06-23	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+8,100 sh	—	—	8,100
2025-02-04	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+60K sh	—	—	60,000
2024-06-14	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+5,750 sh	—	—	5,750
2024-01-26	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+35.5K sh	—	—	35,500
2023-11-09	CRVOCervoMed Inc.G Gift	Director, CEO & President, 10% Owner	GGift	−12.5K sh	—	—	729,539
2023-09-15	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+35.5K sh	—	—	35,500
2023-09-15	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director, CEO & President, 10% Owner	AAward	+6,450 sh	—	—	6,450
2008-07-24	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsA Award	EVP, Med. Dev. Group & CMO	AAward	+36.3K sh	—	—	36,250
2008-06-19	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−3,459 sh	—	—	0
2008-06-19	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−4,822 sh	—	—	0
2008-06-19	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+4,822 sh	$15.87	+$76.5K	133,333
2008-06-19	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+3,459 sh	$15.60	+$54K	136,792
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−1,000 sh	$35.46	−$35.5K	135,960
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−500 sh	—	—	9,400
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+500 sh	$9.07	+$4,535	136,960
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+1,000 sh	$18.47	+$18.5K	136,460
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−500 sh	$35.46	−$17.7K	135,460
2007-01-31	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−1,000 sh	—	—	1,966
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+1,000 sh	$18.47	+$18.5K	104,376
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	+500 sh	$9.07	+$4,535	104,876
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−1,000 sh	$37.56	−$37.6K	103,876
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−500 sh	$37.56	−$18.8K	103,376
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−1,000 sh	—	—	498,995
2006-12-27	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsM Exercise/Conversion	EVP, Med. Dev. Group & CMO	MExercise/Conversion	−500 sh	—	—	498,495
2005-12-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−1,750 sh	$27.59	−$48.3K	88,714
2005-12-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−250 sh	$27.58	−$6,895	90,464
2005-12-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Med. Dev. Group & CMO	SSale	−3,220 sh	$27.40	−$88.2K	90,714
2005-07-20	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	EVP, Med. Dev. Group & CMO	AAward	+18K sh	—	—	421,745
2005-02-03	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	EVP, Med. Dev. Group & CMO	AAward	+24.8K sh	—	—	403,745
2005-02-03	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Med. Dev. Group & CMO	AAward	+5,700 sh	$0.01	+$57	93,934

Recent filings

Accepted (ET)
Jun 104
ALAM JOHN J0001437749-26-020210
SEC(opens sec.gov)
Feb 134
ALAM JOHN J0001437749-26-004162
SEC(opens sec.gov)
Nov 194
ALAM JOHN J0001437749-25-035652
SEC(opens sec.gov)
Nov 174
ALAM JOHN J0001437749-25-035309
SEC(opens sec.gov)
Nov 134
ALAM JOHN J0001437749-25-034638
SEC(opens sec.gov)
Jun 254
ALAM JOHN J0001437749-25-021275
SEC(opens sec.gov)
Feb 144
ALAM JOHN J0001437749-25-004071
SEC(opens sec.gov)
Jun 144
ALAM JOHN J0001437749-24-020414
SEC(opens sec.gov)
Jan 264
ALAM JOHN J0001437749-24-002349
SEC(opens sec.gov)
Nov 94
ALAM JOHN J0001437749-23-031329
SEC(opens sec.gov)
Sep 154
ALAM JOHN J0001437749-23-026076
SEC(opens sec.gov)
Jul 254
ALAM JOHN J0000875320-08-000052
SEC(opens sec.gov)
Jun 234
VERTEX PHARMACEUTICALS INC / MA0000875320-08-000046
SEC(opens sec.gov)

Companies

Address

20 PARK PLAZA, SUITE 424

BOSTON, MA, 02116